OFI Invest Asset Management Has $95,000 Position in GE HealthCare Technologies Inc. $GEHC

OFI Invest Asset Management boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 40.3% during the second quarter, Holdings Channel reports. The institutional investor owned 1,277 shares of the company’s stock after acquiring an additional 367 shares during the quarter. OFI Invest Asset Management’s holdings in GE HealthCare Technologies were worth $95,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. Glenview Trust co boosted its stake in GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after buying an additional 139 shares in the last quarter. Silver Oak Securities Incorporated boosted its stake in GE HealthCare Technologies by 4.6% during the second quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock worth $236,000 after buying an additional 140 shares in the last quarter. Chicago Capital LLC boosted its stake in GE HealthCare Technologies by 2.2% during the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock worth $485,000 after buying an additional 141 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in GE HealthCare Technologies by 4.2% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock worth $263,000 after buying an additional 143 shares in the last quarter. Finally, Knuff & Co LLC boosted its stake in GE HealthCare Technologies by 1.5% during the first quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock worth $829,000 after buying an additional 150 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $71.84 on Tuesday. The stock has a 50-day simple moving average of $74.33 and a 200 day simple moving average of $72.16. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The stock has a market capitalization of $32.80 billion, a price-to-earnings ratio of 14.72, a P/E/G ratio of 2.71 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the previous year, the business posted $1.00 earnings per share. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.87%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. BTIG Research boosted their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday. Weiss Ratings restated a “hold (c)” rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their target price for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Finally, Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.